These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Association of downregulated HDAC 2 with the impaired mitochondrial function and cytokine secretion in the monocytes/macrophages from gestational diabetes mellitus patients. Qu X; Yu H; Jia B; Yu X; Cui Q; Liu Z; Sun C; Chu Y Cell Biol Int; 2016 Jun; 40(6):642-51. PubMed ID: 26936353 [TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21 deficiency attenuated atherogenesis and decreased macrophage infiltration by targeting Dusp-8. Gao L; Zeng H; Zhang T; Mao C; Wang Y; Han Z; Chen K; Zhang J; Fan Y; Gu J; Wang C Atherosclerosis; 2019 Dec; 291():78-86. PubMed ID: 31704554 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages. Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405 [TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase regulates trypsin activation, inflammation, and tissue damage in acute pancreatitis in mice. Hartman H; Wetterholm E; Thorlacius H; Regnér S Dig Dis Sci; 2015 May; 60(5):1284-9. PubMed ID: 25492506 [TBL] [Abstract][Full Text] [Related]
30. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target]. Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. Halili MA; Andrews MR; Labzin LI; Schroder K; Matthias G; Cao C; Lovelace E; Reid RC; Le GT; Hume DA; Irvine KM; Matthias P; Fairlie DP; Sweet MJ J Leukoc Biol; 2010 Jun; 87(6):1103-14. PubMed ID: 20200406 [TBL] [Abstract][Full Text] [Related]
32. Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Bekkering S; van den Munckhof I; Nielen T; Lamfers E; Dinarello C; Rutten J; de Graaf J; Joosten LA; Netea MG; Gomes ME; Riksen NP Atherosclerosis; 2016 Nov; 254():228-236. PubMed ID: 27764724 [TBL] [Abstract][Full Text] [Related]
33. Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis. Vasamsetti SB; Karnewar S; Gopoju R; Gollavilli PN; Narra SR; Kumar JM; Kotamraju S Free Radic Biol Med; 2016 Jul; 96():392-405. PubMed ID: 27156686 [TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanism of the Protective Effect of Zerumbone on Lipopolysaccharide-Induced Inflammation of THP-1 Cell-Derived Macrophages. Kim MJ; Yun JM J Med Food; 2019 Jan; 22(1):62-73. PubMed ID: 30383973 [TBL] [Abstract][Full Text] [Related]
36. The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis. Bekkering S; Joosten LA; van der Meer JW; Netea MG; Riksen NP Clin Ther; 2015 Apr; 37(4):914-23. PubMed ID: 25704108 [TBL] [Abstract][Full Text] [Related]
37. Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis. Zhang X; Huang F; Li W; Dang JL; Yuan J; Wang J; Zeng DL; Sun CX; Liu YY; Ao Q; Tan H; Su W; Qian X; Olsen N; Zheng SG Front Immunol; 2018; 9():878. PubMed ID: 29760701 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis. Jia SJ; Gao KQ; Zhao M Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371472 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension. Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117 [TBL] [Abstract][Full Text] [Related]
40. Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule. Chriett S; Dąbek A; Wojtala M; Vidal H; Balcerczyk A; Pirola L Sci Rep; 2019 Jan; 9(1):742. PubMed ID: 30679586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]